FDA expansion of abortion pill use still does not necessarily mean chemical abortion is safer
By Randall K. O’Bannon, Ph.D., NRL Director of Education & Research Many suspected that today’s announcement by the FDA was a long time coming. Despite a record of at least 14 known deaths, and thousands of women suffering significant adverse events, the FDA relaxed safety standards and modified the protocol for mifepristone/misoprostol chemical abortions that had …
Continue reading "FDA expansion of abortion pill use still does not necessarily mean chemical abortion is safer"